EUVIMEDEUVIMED entdecken
Crossref

SGLT2 Inhibition as a Novel "Metabolic Aquaretic" to Correct Thiazide-Induced Hyponatremia

Negiin Pourafshar, Siddharth S. Madapoosi, Karina Han, Christopher Stuart Wilcox

Journal of the American Society of Nephrology · 2026-10 · 37 (10S)

DOI: 10.1681/asn.202617ft0jda ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Society of Nephrology, 2026-10. Verfasst von Negiin Pourafshar und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Pourafshar, N., Madapoosi, S. S., Han, K., & Wilcox, C. S. (2026). SGLT2 Inhibition as a Novel "Metabolic Aquaretic" to Correct Thiazide-Induced Hyponatremia. Journal of the American Society of Nephrology, 37(10S). https://doi.org/10.1681/asn.202617ft0jda

Vancouver

Pourafshar N, Madapoosi SS, Han K, Wilcox CS. SGLT2 Inhibition as a Novel "Metabolic Aquaretic" to Correct Thiazide-Induced Hyponatremia. Journal of the American Society of Nephrology. 2026;37(10S). doi:10.1681/asn.202617ft0jda

BibTeX
@article{Pourafshar2026,
  author = {Pourafshar, Negiin and Madapoosi, Siddharth S. and Han, Karina and Wilcox, Christopher Stuart},
  title = {SGLT2 Inhibition as a Novel "Metabolic Aquaretic" to Correct Thiazide-Induced Hyponatremia},
  journal = {Journal of the American Society of Nephrology},
  year = {2026},
  volume = {37},
  number = {10S},
  doi = {10.1681/asn.202617ft0jda}
}
Kostenlos starten →